oxazoles has been researched along with paclitaxel in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, A; Kohno, M; Yamaguchi, H | 1 |
| Nozaki, Y; Shintani, Y; Tanaka, T | 1 |
| Craig, RW; Domina, AM; Smith, JH | 1 |
| Bulinski, JC; Faire, K; Gruber, D | 1 |
| Meraldi, P; Nigg, EA | 1 |
| Hida, T; Ito, H; Kozaki, K; Matsuo, K; Miyaishi, O; Ogawa, M; Sugiura, T; Suzuki, T; Takahashi, T; Tatematsu, Y | 1 |
| Kobayashi, J; Mitsui-Saito, M; Nakahata, N; Obara, Y; Ohizumi, Y; Ohkubo, S; Yanagisawa, T | 1 |
| Claiborne, A; Credo, RB; Frost, DJ; Gwaltney, SL; Li, Q; Ng, SC; Nukkala, MA; Rosenberg, SH; Sham, HL; Tahir, SK; Warner, RB; Woods, KW; Zielinski Mozny, NA | 1 |
| Chan Kwon, I; Cheon Lee, S; Chung, H; Kim, C; Young Jeong, S | 1 |
| Cieslak, J; Ilkevitch, Y; Kuznyetsov, V; Shkumatov, A; Verlinsky, Y | 1 |
| Batrakova, EV; Bronich, TK; Jordan, R; Kabanov, AV; Li, S; Luxenhofer, R; Roques, C; Schulz, A | 1 |
| Hu, W; Jiang, L; Prajapati, D; Qian, Y; Xu, X | 1 |
| Chen, YC; Hsieh, WY; Lee, WF; Tsai, HH | 1 |
| Di, Z; Han, Y; Jaksch, S; Jordan, R; Kabanov, AV; Kressler, J; Luxenhofer, R; Meister, A; Papadakis, CM; Schubel, R; Schulz, A; Wegener, E | 1 |
| Alakhova, D; Bludau, H; Darr, DB; Dobrovolskaia, MA; He, Z; Jordan, R; Kabanov, AV; Li, Z; Luxenhofer, R; Montgomery, SA; Perou, CM; Schulz, A; Sokolsky, M; Stern, ST; Wan, X; Yuan, H | 1 |
| Hahn, L; Haider, MS; Lübtow, MM; Luxenhofer, R | 1 |
| Chen, S; Qi, C; Shen, Z; Wang, G; Wang, X; Williams, N; Yu, H | 1 |
| Appelt-Menzel, A; Dahms, S; Gangloff, N; Keßler, L; Kirsch, M; Lorson, T; Lübtow, MM; Luxenhofer, R | 1 |
| Ehrsam, D; Lengerke, C; Meyer Zu Schwabedissen, HE; Porta, F | 1 |
| Beaudoin, JJ; Bludau, H; Jordan, R; Kabanov, AV; Makita, N; Min, Y; Sokolsky, M; Vinod, N; Wan, X; Wang, A | 1 |
| Aseyev, V; Böttcher, B; Endres, S; Flegler, VJ; Forster, S; Haider, MS; Lübtow, MM; Luxenhofer, R; Pöppler, AC | 1 |
| Rugo, HS | 1 |
| Brown, SP; Grüne, M; Iuga, D; Luxenhofer, R; Pöppler, AC | 1 |
| Ghazanfari, L; Kabanov, AV; Master, A; Seo, Y; Sokolsky-Papkov, M; Vishwasrao, HM; Wan, X | 1 |
24 other study(ies) available for oxazoles and paclitaxel
| Article | Year |
|---|---|
[Application of NGF/PC12 cell system for screening tubulin inhibitors].
Topics: Animals; Anti-Bacterial Agents; Cell Cycle; Cell Division; Cytochalasin B; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Marine Toxins; Microtubules; Nerve Growth Factors; Oxazoles; Paclitaxel; PC12 Cells; Rats; Thiazines; Tubulin Modulators; Tumor Cells, Cultured | 1997 |
GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol.
Topics: Animals; Antineoplastic Agents; Biopolymers; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; HeLa Cells; Humans; Oxazoles; Paclitaxel; Structure-Activity Relationship; Swine; Tubulin | 1997 |
Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.
Topics: Burkitt Lymphoma; Cell Cycle; Cell Survival; Enzyme Activation; Enzyme Inhibitors; G2 Phase; Humans; Marine Toxins; Microtubules; Mitogen-Activated Protein Kinases; Mitosis; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Nocodazole; Okadaic Acid; Oxazoles; Paclitaxel; Phosphorylation; Protein Kinase C; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vinblastine | 2000 |
Abundant expression of the microtubule-associated protein, ensconsin (E-MAP-115), alters the cellular response to Taxol.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chlorocebus aethiops; Drug Screening Assays, Antitumor; Drug Synergism; Epithelial Cells; Green Fluorescent Proteins; HeLa Cells; Humans; Kidney; Luminescent Proteins; Mice; Microtubule-Associated Proteins; Microtubules; Oxazoles; Paclitaxel; Protein Binding; Rats; Recombinant Fusion Proteins; Species Specificity; Tumor Cells, Cultured; Verapamil; Vinblastine | 2001 |
Centrosome cohesion is regulated by a balance of kinase and phosphatase activities.
Topics: Antineoplastic Agents; Aurora Kinases; Cell Cycle; Cell Cycle Proteins; Centrosome; Cyclin-Dependent Kinases; Cyclins; Cytochalasin D; Cytoskeleton; Enzyme Inhibitors; Humans; Marine Toxins; Microtubules; NIMA-Related Kinases; Nocodazole; Nucleic Acid Synthesis Inhibitors; Okadaic Acid; Oxazoles; Paclitaxel; Phosphoprotein Phosphatases; Phosphorylation; Polo-Like Kinase 1; Protein Kinases; Protein Phosphatase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Transfection; Tumor Cells, Cultured; Xenopus Proteins | 2001 |
Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.
Topics: Adenocarcinoma; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Isoenzymes; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Oxazoles; Paclitaxel; Prostaglandin-Endoperoxide Synthases; Taxoids; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2002 |
Theonezolide A, a novel marine macrolide, induces drastic shape change in rabbit platelets by reorganization of microtubules.
Topics: Animals; Blood Platelets; Cell Size; Cytochalasin B; In Vitro Techniques; Macrolides; Male; Microscopy, Electron, Scanning; Microtubule Proteins; Microtubules; Oxazoles; Paclitaxel; Rabbits; Thiazoles; Thrombin | 2002 |
Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Caspase 3; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Division; Colchicine; Dose-Response Relationship, Drug; Female; Humans; In Situ Nick-End Labeling; Indoles; Mice; Mice, Inbred C57BL; Mitosis; Oxazoles; Paclitaxel; Sarcoma, Experimental; Tubulin; Tumor Cells, Cultured; Vincristine | 2003 |
Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel.
Topics: Animals; Caproates; Cell Line, Tumor; Drug Carriers; Humans; Lactones; Male; Micelles; Oxazoles; Paclitaxel; Polymers; Rats; Rats, Sprague-Dawley | 2003 |
Obtaining metaphase spreads from single blastomeres for PGD of chromosomal rearrangements.
Topics: Animals; Blastomeres; Caffeine; Chromosome Aberrations; Culture Media; Cytoplasm; Demecolcine; Embryo Culture Techniques; Humans; Marine Toxins; Metaphase; Mice; Oxazoles; Paclitaxel; Preimplantation Diagnosis; Zygote | 2007 |
Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Complement Activation; Female; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Inbred C57BL; Micelles; Neoplasms; Oxazoles; Paclitaxel; Polymers; Solubility | 2010 |
A strategy to synthesize taxol side chain and (-)-epi cytoxazone via chiral Brønsted acid-Rh(2)(OAc)(4) co-catalyzed enantioselective three-component reactions.
Topics: Acids; Catalysis; Organometallic Compounds; Oxazoles; Paclitaxel; Stereoisomerism; Substrate Specificity | 2010 |
Paclitaxel and iron oxide loaded multifunctional nanoparticles for chemotherapy, fluorescence properties, and magnetic resonance imaging.
Topics: Amines; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Drug Therapy; Female; Ferric Compounds; Folic Acid; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Nanoparticles; Oxazoles; Paclitaxel; Polyesters; Polyethylene Glycols; Polyglactin 910; Polymers; Solutions; Spectrometry, Fluorescence | 2012 |
Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Hydrophobic and Hydrophilic Interactions; Micelles; Models, Molecular; Molecular Conformation; Oxazoles; Paclitaxel; Solubility | 2014 |
A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Carriers; Female; Humans; Mice; Mice, Inbred BALB C; Micelles; Ovarian Neoplasms; Oxazoles; Paclitaxel | 2016 |
Drug Specificity, Synergy and Antagonism in Ultrahigh Capacity Poly(2-oxazoline)/Poly(2-oxazine) based Formulations.
Topics: Antineoplastic Agents; Curcumin; Drug Carriers; Micelles; Oxazines; Oxazoles; Paclitaxel; Solubility; Surface-Active Agents; Water | 2017 |
Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells.
Topics: Animals; Antimitotic Agents; Antineoplastic Agents; Apoptosis; Autocrine Communication; Caspase 8; Cell Cycle Checkpoints; Cell Line, Tumor; Ligands; M Phase Cell Cycle Checkpoints; Mice, Nude; Neoplasms; Oxazoles; Paclitaxel; Receptors, Tumor Necrosis Factor, Member 25; Recombinant Proteins; Tumor Necrosis Factor Ligand Superfamily Member 15 | 2018 |
More Is Sometimes Less: Curcumin and Paclitaxel Formulations Using Poly(2-oxazoline) and Poly(2-oxazine)-Based Amphiphiles Bearing Linear and Branched C9 Side Chains.
Topics: Cells, Cultured; Curcumin; Fibroblasts; Humans; Oxazoles; Paclitaxel; Solubility | 2018 |
Synthesis and Characterization of PDMS-PMOXA-Based Polymersomes Sensitive to MMP-9 for Application in Breast Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Carriers; Drug Liberation; Embryo, Nonmammalian; Female; Humans; Matrix Metalloproteinase 9; MCF-7 Cells; Nanoparticles; Oxazoles; Paclitaxel; Polymers; Treatment Outcome; Xenograft Model Antitumor Assays; Zebrafish | 2018 |
Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Drug Carriers; Drug Liberation; Female; Humans; Mice, Nude; Micelles; Ovarian Neoplasms; Oxazoles; Paclitaxel | 2019 |
Think Beyond the Core: Impact of the Hydrophilic Corona on Drug Solubilization Using Polymer Micelles.
Topics: Curcumin; Drug Carriers; Drug Compounding; Hydrophobic and Hydrophilic Interactions; Micelles; Molecular Structure; Oxazoles; Paclitaxel; Polymers; Small Molecule Libraries; Solubility; Surface-Active Agents | 2020 |
Highlights from the 2019 San Antonio Breast Cancer Symposium.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Female; Humans; Immunoconjugates; Oxazoles; Paclitaxel; Prognosis; Pyridines; Quinazolines; Texas; Trastuzumab | 2020 |
Topics: Drug Compounding; Magnetic Resonance Spectroscopy; Micelles; Oxazoles; Paclitaxel | 2020 |
Poly(2-oxazoline)-magnetite NanoFerrogels: Magnetic field responsive theranostic platform for cancer drug delivery and imaging.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Ferrosoferric Oxide; Humans; Magnetic Fields; Micelles; Oxazoles; Paclitaxel; Precision Medicine | 2022 |